Drugmaker Aspen targets Mounjaro approval in sub-Saharan Africa this year

Investing.com Gold reports: Drugmaker Aspen targets Mounjaro approval in sub-Saharan Africa this year. This is a premium/paywalled source, so the brief is based on headline and available metadata only.